Bright Minds Biosciences (DRUG) Free Cash Flow (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Free Cash Flow of -$6.7 million for Q1 2026, down 61.67% on a QoQ basis from -$4.2 million in Q4 2025, and down 498.9% year-over-year from $1.7 million in Q1 2025.
Bright Minds Biosciences (DRUG) Free Cash Flow (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$6.7 million for Q1 2026.
- Quarterly Free Cash Flow fell 498.9% year-over-year to -$6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.0 million (down 9572.95% YoY) and the FY2025 annual result came in at -$6.3 million, down 365.66% from the prior year.
- Free Cash Flow was -$6.7 million for Q1 2026 at Bright Minds Biosciences, down from -$4.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $2.9 million in Q1 2022 and bottomed at -$19.2 million in Q3 2022.
- A 5-year average of -$2.2 million and a median of $597467.2 in 2024 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 182.9% in 2025, while the deepest fall reached 4562.31% in 2025.
- Bright Minds Biosciences' Free Cash Flow stood at $2.0 million in 2022, then tumbled by 69.23% to $603852.1 in 2023, then jumped by 77.16% to $1.1 million in 2024, then tumbled by 489.85% to -$4.2 million in 2025, then plunged by 61.67% to -$6.7 million in 2026.
- Business Quant data shows DRUG's Free Cash Flow at -$6.7 million in Q1 2026, -$4.2 million in Q4 2025, and -$921379.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | -6.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.74 Mn |
| Mar 31, 2026 | -6.74 Mn |
| Dec 31, 2025 | -4.17 Mn |
| Dec 31, 2025 | -4.17 Mn |
| Sep 30, 2025 | -921,379.00 |
| Sep 30, 2025 | -921,379.00 |
| Jun 30, 2025 | -8.19 Mn |
| Jun 30, 2025 | -8.19 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | -2.37 Mn |
| Sep 30, 2024 | -2.37 Mn |
| Jun 30, 2024 | -175,590.71 |
| Jun 30, 2024 | -175,590.71 |
| Mar 31, 2024 | 597,467.18 |
| Mar 31, 2024 | 597,467.18 |
| Dec 31, 2023 | 603,852.11 |
| Dec 31, 2023 | 603,852.11 |